Date published: 2025-12-24

1-800-457-3801

SCBT Portrait Logo
Seach Input

ZSCAN4 Inhibitors

ZSCAN4 inhibitors refer to a class of chemical compounds that specifically target and inhibit the activity of the ZSCAN4 (Zinc finger and SCAN domain-containing 4) protein. ZSCAN4 is a transcription factor that plays a significant role in maintaining genomic stability and telomere elongation, particularly in embryonic stem cells and during the early stages of development. Structurally, ZSCAN4 contains a zinc finger domain, which is characteristic of proteins involved in DNA binding, and a SCAN domain, known to mediate protein-protein interactions. By interacting with specific DNA sequences, ZSCAN4 modulates gene expression patterns that influence chromosomal integrity and telomeric dynamics. Inhibitors of ZSCAN4 function by interfering with this transcription factor's ability to bind to its target DNA sequences or by destabilizing its interactions with other proteins, ultimately disrupting its regulatory functions.

The inhibition of ZSCAN4 can provide a useful tool for studying its role in cellular processes such as chromosomal rearrangement, telomere maintenance, and cellular reprogramming. These inhibitors enable researchers to explore the downstream molecular effects caused by the loss of ZSCAN4 function, which can include alterations in telomeric length, changes in chromatin structure, and effects on cellular senescence. Moreover, the chemical properties of ZSCAN4 inhibitors, including their ability to cross cell membranes and their specificity for the ZSCAN4 protein, are essential factors in understanding their biological activity. Through detailed biochemical studies, these inhibitors can shed light on the molecular mechanisms governing chromosomal stability, cellular aging, and the maintenance of genomic integrity. By disrupting ZSCAN4's function, researchers can investigate how cells respond to genomic instability and gain deeper insights into fundamental cellular processes.

SEE ALSO...

Items 1 to 10 of 12 total

Display:

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Suberoylanilide Hydroxamic Acid

149647-78-9sc-220139
sc-220139A
100 mg
500 mg
$130.00
$270.00
37
(2)

Might influence the acetylation state of histones, possibly affecting the transcription of the ZSCAN4 gene by altering chromatin accessibility.

Y-27632, free base

146986-50-7sc-3536
sc-3536A
5 mg
50 mg
$182.00
$693.00
88
(1)

Could inhibit Rho-associated protein kinase (ROCK), potentially influencing cellular processes that might indirectly affect ZSCAN4 expression.

Valproic Acid

99-66-1sc-213144
10 g
$85.00
9
(1)

Might influence ZSCAN4 expression by inhibiting histone deacetylases, altering chromatin configuration.

Hydroxyurea

127-07-1sc-29061
sc-29061A
5 g
25 g
$76.00
$255.00
18
(1)

Could inhibit DNA synthesis, possibly affecting the cell cycle and indirectly influencing ZSCAN4 gene expression.

Actinomycin D

50-76-0sc-200906
sc-200906A
sc-200906B
sc-200906C
sc-200906D
5 mg
25 mg
100 mg
1 g
10 g
$73.00
$238.00
$717.00
$2522.00
$21420.00
53
(3)

Might bind to DNA and inhibit RNA synthesis, potentially affecting ZSCAN4 mRNA production.

Mitomycin C

50-07-7sc-3514A
sc-3514
sc-3514B
2 mg
5 mg
10 mg
$65.00
$99.00
$140.00
85
(5)

Could crosslink DNA, potentially inhibiting transcription processes and impacting ZSCAN4 expression.

Camptothecin

7689-03-4sc-200871
sc-200871A
sc-200871B
50 mg
250 mg
100 mg
$57.00
$182.00
$92.00
21
(2)

Might inhibit DNA topoisomerase I, possibly affecting DNA replication and indirectly influencing ZSCAN4 expression.

Cycloheximide

66-81-9sc-3508B
sc-3508
sc-3508A
100 mg
1 g
5 g
$40.00
$82.00
$256.00
127
(5)

Could inhibit protein synthesis, potentially impacting the overall expression levels of ZSCAN4 protein.

α-Amanitin

23109-05-9sc-202440
sc-202440A
1 mg
5 mg
$260.00
$1029.00
26
(2)

Might inhibit RNA polymerase II, possibly affecting the transcription of ZSCAN4 mRNA.

Geldanamycin

30562-34-6sc-200617B
sc-200617C
sc-200617
sc-200617A
100 µg
500 µg
1 mg
5 mg
$38.00
$58.00
$102.00
$202.00
8
(1)

Could inhibit Hsp90, potentially affecting the folding and stability of client proteins including ZSCAN4.